Mitochondrial Transplantation: A Paradigm Shift in Osteoporosis Therapy

Area of Science:

• Bone Biology and Disease
• Mitochondrial Medicine
• Regenerative Therapeutics

Background:

• Osteoporosis is a major global health issue characterized by low bone density and increased fracture risk.
• Mitochondrial dysfunction significantly contributes to the imbalance between bone-forming osteoblasts and bone-resorbing osteoclasts.
• Current osteoporosis treatments primarily focus on anti-resorptive therapies, necessitating novel approaches.

Purpose of the Study:

• To review the role of mitochondrial dynamics in bone homeostasis and osteoporosis.
• To explore the potential of mitochondrial transplantation (MT) as a therapeutic strategy for osteoporosis.
• To discuss advancements in delivery platforms and challenges for clinical translation of MT.

Main Methods:

• Review of current literature on mitochondrial function in bone metabolism and osteoporosis.
• Analysis of preclinical data demonstrating the efficacy of MT in osteoporosis models.
• Discussion of intercellular mitochondrial trafficking and bioengineered delivery systems.

Main Results:

• Mitochondrial transplantation effectively restored bone mass, microarchitecture, and mechanical strength in preclinical osteoporosis models.
• Intercellular mitochondrial trafficking via osteocyte networks plays a role in bone health.
• Novel delivery platforms and strategies for clinical translation are being developed.

Conclusions:

• Mitochondrial dysfunction is a key factor in osteoporosis pathogenesis.
• Mitochondrial transplantation offers a promising, novel therapeutic avenue for osteoporosis.
• Personalized mitochondrial medicine, integrating omics data and AI, will guide future osteoporosis treatments.